
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening
Author(s) -
Ahmedin Jemal,
MaryBeth Culp,
Jiemin Ma,
Farhad Islami,
Stacey A. Fedewa
Publication year - 2020
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djaa068
Subject(s) - medicine , incidence (geometry) , demography , ethnic group , prostate cancer , cancer , gerontology , disease , stage (stratigraphy) , paleontology , physics , sociology , anthropology , optics , biology
Previous studies reported that prostate cancer incidence rates in the United States declined for local-stage disease and increased for regional- and distant-stage disease following the US Preventive Services Task Force recommendations against prostate-specific antigen-based screening for men aged 75 years and older in 2008 and for all men in 2012. It is unknown, however, whether these patterns persisted through 2016.